To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...

TCT 1019: Complex degenerative mitral valve disease with a posterior cleft and severe regurgitation successfully treated using a single PASCAL Ace device with horizontal positioning. Receive the the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Study honoraria to ...

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003 In this phase IIb parallel cohort study, patients with ...

Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...

First and only drug releasing system is indicated for patients with BCG-unresponsive non-muscle-invasive bladder cancer seeking bladder preservation ...